Tetsuharu Yoneo
Direktor/Vorstandsmitglied bei Emendo Biotherapeutics, Inc.
Aktive Positionen von Tetsuharu Yoneo
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Emendo Biotherapeutics, Inc.
 Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Emendo Biotherapeutics, Inc. engages in the development of genome editing technology. It specializes in protein engineering, molecular biology, and gene editing systems. The company was founded by David Baram, Lior Izhar, and Rachel Diamant in 2015 and is headquartered in New York, NY. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Tetsuharu Yoneo
Statistik
International
| Vereinigte Staaten | 2 |
Operativ
| Director/Board Member | 1 |
Sektoral
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Emendo Biotherapeutics, Inc.
Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Emendo Biotherapeutics, Inc. engages in the development of genome editing technology. It specializes in protein engineering, molecular biology, and gene editing systems. The company was founded by David Baram, Lior Izhar, and Rachel Diamant in 2015 and is headquartered in New York, NY. | Health Technology |
- Börse
- Insiders
- Tetsuharu Yoneo
- Erfahrung
